ENTITY

Personalis Inc (PSNL US)

7
Analysis
Health Care • United States
Personalis, Inc. provides genomic sequencing and analytics solutions. The Company supports the development of personalized cancer vaccines and other next-generation cancer immunotherapies. Personalis serves customers worldwide.
more
bullish•Personalis Inc
•18 Jun 2019 17:18

Personalis IPO: Personalising Cancer Trials and Treatments; Upside from Growth in Cancer Market

Personalis offers genomic sequencing to bio-pharmaceutical companies by fully analyzing sample tissue data of cancer patients. It provides its...

Share
x